Class A G Protein-Coupled Receptor Antagonist Famotidine as a Therapeutic Alternative Against SARS-CoV2: An In Silico Analysis
The pandemic associated with Severe Acute Respiratory Syndrome Coronavirus type 2 (SARS-CoV2) and its disease named COVID-19 challenged the scientific community to discover effective therapeutic solutions in a short period. Repurposing existing drugs is one viable approach that emphasizes speed duri...
Main Authors: | Joseph T. Ortega, Maria Luisa Serrano, Beata Jastrzebska |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-06-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/10/6/954 |
Similar Items
-
GRL-0920, an Indole Chloropyridinyl Ester, Completely Blocks SARS-CoV-2 Infection
by: Shin-ichiro Hattori, et al.
Published: (2020-08-01) -
Flavonoids with inhibitory activity against SARS-CoV-2 3CLpro
by: Seri Jo, et al.
Published: (2020-01-01) -
A Study of 3CLpros as Promising Targets against SARS-CoV and SARS-CoV-2
by: Seri Jo, et al.
Published: (2021-04-01) -
Sub-Micromolar Inhibition of SARS-CoV-2 3CLpro by Natural Compounds
by: Bruno Rizzuti, et al.
Published: (2021-09-01) -
Coronavirus (SARS-CoV-2): Preventions, keys to diagnosis and treatment of SARS-CoV-2
by: Kuldeep Singh Patel, et al.
Published: (2020-03-01)